Quality Measurement as a Path to High Quality Care; Comment on “Quality and Performance Measurement in Primary Diabetes Care: A Qualitative Study in Urban China”

Document Type : Commentary


1 Division of Community Internal Medicine, Geriatrics and Palliative Care, Department of Medicine, Mayo Clinic, Rochester, MN, USA

2 Division of Endocrinology, Diabetes & Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

3 Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA

4 University of Maryland Institute for Health Computing, Bethesda, MD, USA


A rigorous evaluation of the implementation of a diabetes quality measure implementation program across community healthcare clinics in Shanghai, China, where both quality measurement and primary care delivery are relatively recent but centrally supported, identified important concerns about the meaningfulness, feasibility, and accuracy of quality measures that are relevant to all quality measurement programs. These include the importance of stakeholder involvement in measure development and implementation, the need to select measures that accurately and reliably reflect care quality, the link between incentives for improved performance and data manipulation, the necessity for scientific credibility and practical feasibility of the measure, and the assurance that measure performance can be impacted by those being evaluated. In addition to elaborating on these aspects of quality measurement, we also discuss the need for quality measures that are balanced across established domains of quality, are not burdensome to participants, and are transparent, parsimonious, nimble, and oriented around continuous evaluation and improvement. 


  1. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843. doi:1016/j.diabres.2019.107843
  2. Neuhauser D. Ernest Amory Codman MD. Qual Saf Health Care. 2002;11(1):104-105. doi:1136/qhc.11.1.104
  3. Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q. 1966;44(3):166-206.
  4. Donabedian A. The quality of care. How can it be assessed? JAMA. 1988;260(12):1743-1748. doi:1001/jama.260.12.1743
  5. Institute of Medicine (IOM). Committee on Quality of Health Care in America: Crossing the Quality Chasm: A New Health System for the 21st Century. IOM; 2001.
  6. McGlynn EA, Schneider EC, Kerr EA. Reimagining quality measurement. N Engl J Med. 2014;371(23):2150-2153. doi:1056/NEJMp1407883
  7. Rasooly A, Pan Y, Tang Z, et al. Quality and performance measurement in primary diabetes care: a qualitative study in urban China. Int J Health Policy Manag. 2022;11(12):3019-3031. doi:34172/ijhpm.2022.6372
  8. American Diabetes Association. 6. Glycemic targets: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S73-S84. doi:2337/dc21-S006
  9. Hill-Briggs F, Adler NE, Berkowitz SA, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2020;44(1):258-279. doi:2337/dci20-0053
  10. Bergerum C, Thor J, Josefsson K, Wolmesjö M. How might patient involvement in healthcare quality improvement efforts work-a realist literature review. Health Expect. 2019;22(5):952-964. doi:1111/hex.12900
  11. Baumhauer JF. Patient-reported outcomes - are they living up to their potential? N Engl J Med. 2017;377(1):6-9. doi:1056/NEJMp1702978
  12. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. doi:1136/bmj.328.7454.1490
  13. Jiang DH, O'Connor PJ, Huguet N, Golden SH, McCoy RG. Modernizing diabetes care quality measures. Health Aff (Millwood). 2022;41(7):955-962. doi:1377/hlthaff.2022.00233
  14. Nelson EC, Mohr JJ, Batalden PB, Plume SK. Improving health care, part 1: the clinical value compass. Jt Comm J Qual Improv. 1996;22(4):243-258. doi:1016/s1070-3241(16)30228-0
  15. LaVecchia CM, Montori VM, Shah ND, McCoy RG. Values informing the development of an indicator of appropriate diabetes therapy: qualitative study. BMJ Open. 2020;10(12):e044395. doi:1136/bmjopen-2020-044395

Articles in Press, Accepted Manuscript
Available Online from 02 September 2023
  • Receive Date: 13 December 2022
  • Revise Date: 26 August 2023
  • Accept Date: 30 August 2023
  • First Publish Date: 02 September 2023